Pricing Log in Create free account
Friday 6 November 2026 Export XERS’s income statement to Excel — free account

Xeris Biopharma Holdings, Inc.

XERS Healthcare Drug Manufacturers Specialty & Generic

Xeris Biopharma Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $291.8 million, up 43.7% from fiscal 2024.

Revenue
+44.2%
EPS
+1,479.0%
Free cash flow
+93.2%
Total debt
−13.6%

Quarter to September 2026, against a year earlier

15.16 2.08 +15.90%
Market cap
$2.4B
P/E
0.0×
Fwd P/E
−143×
Dividend yield
—
F-score
8/9
Altman Z
0.98
Beneish M
−2.58
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Xeris Biopharma Holdings, Inc. (XERS) Net margin

Alert me on Net margin

Xeris Biopharma Holdings, Inc.'s net margin over the twelve months to 30 September 2026 was −1.76%, down 2.0 percentage points from fiscal 2025 (0.19%). Over the past ten years it has ranged from −4,613.5% (fiscal 2019) to 0.19% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of −2.31% and below the Healthcare sector median of 0.00%.

Net margin, annual

Embed this chart

Annual newest first

Period Net margin Change (points)
FY2025 0.19% 27.19
FY2024 −27.0% 10.98
FY2023 −38.0% 47.88
FY2022 −85.9% 161.62
FY2021 −247.5% 198.52
FY2020 −446.0% 4,167.52
FY2019 −4,613.5% (2,133.95)
FY2018 −2,479.6% (773.01)
FY2017 −1,706.6% (477.82)
FY2016 −1,228.7% —

Quarterly newest first

Period Net margin Change (points)
Sep 2026 10.5% 44.30
Jun 2026 −33.8% (36.46)
Mar 2026 2.69% (10.22)
Dec 2025 12.9% 12.08
33 more quarters

Against its own ten years

Low −4,613.5% High 0.19%
Ten-year median −346.7%
Current reading's percentile 94

Net margin against peers

Company Net margin
PBH Prestige Consumer Healthcare Inc. compare 13.3%
AMLX Amylyx Pharmaceuticals, Inc. compare 0.00%
RGC Regencell Bioscience Holdings Limited compare 0.00%
XERS Xeris Biopharma Holdings, Inc. −1.76%
HCM HUTCHMED (China) Limited Sponsored ADR compare −23.6%
BCRX BioCryst Pharmaceuticals, Inc. compare −37.4%
TRLV Trulieve Cannabis Corp. compare −41.2%
PRGO Perrigo Company plc compare −43.3%
ALVO Alvotech compare −101.1%
Drug Manufacturers Specialty & Generic industry median −2.31%
Healthcare sector median 0.00%
Market median 1.14%

What Net margin is

Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.

Net Income Allotted to Shareholders ÷ Revenue

The full definition of Net margin →

More on XERS